OICS v0.3.3 class · Healthcare

Generics & Consumer Health

ID GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,225 Listed with filings838

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
ANIMALCARE GROUP PLC	ANCR	United Kingdom	$233.81M	393
Laboratorio Reig Jofre S.A.	RJF	Spain	$252.47M	255
YUNGJIN PHARM. CO., LTD	003520	South Korea	$212.66M	970
KWANGDONG PHARMACEUTICAL CO.,LTD	009290	South Korea	$202.65M	1,066
Formosa Laboratories, Inc.	4746	Taiwan	$199.69M	2,067
KOREA UNITED PHARM INC	033270	South Korea	$169.27M	1,290
Sinphar Pharmaceutical Co., Ltd.	1734	Taiwan	$185.82M	2,066
JW HOLDINGS CORPORATION	096760	South Korea	$169.83M	1,229
BGM Group Ltd.	BGM	United States of America	$173.96M	153
EQL Pharma AB	EQL	Sweden	$72.68M	101
Paon-Fu-Chin Biotechnology Co., Ltd.	1760	Taiwan	$164.05M	1,705
SAMJIN PHARMACEUTICAL CO.,LTD	005500	South Korea	$163.49M	879
Hyloris Pharmaceuticals SA	HYL	Belgium	$142.56M	256
SCI Pharmaceuticals, Inc.	4119	Taiwan	$166.75M	1,980
HYUNDAI PHARMACEUTICAL CO., LTD	004310	South Korea	$106.12M	1,043
DAEWON PHARMACEUTICAL CO.,LTD	003220	South Korea	$147.85M	1,126
Cenra Inc.	3716	Taiwan	$161.32M	466
EuroAPI	EAPI	France	$143.25M	259
Johnson Chemical Pharmaceutical Works CO.,LTD	4747	Taiwan	$141.76M	1,403
Xspray Pharma	XSPRAY	Sweden	$90.32M	266
SAMIL PHARMACEUTICAL CO.,LTD	000520	South Korea	$100.12M	987
JW LIFESCIENCE CORPORATION	234080	South Korea	$113.72M	358
JEIL PHARMACEUTICAL CO.,LTD	271980	South Korea	$101.63M	214
REYON PHARMACEUTICAL CO., LTD	102460	South Korea	$124.08M	595
KYONGBO PHARMACEUTICAL CO., LTD.	214390	South Korea	$83.01M	383
SAMSUNG PHARMACEUTICAL.CO.,Ltd.	001360	South Korea	$87.28M	1,181
Nang Kuang Pharmaceutical Co., Ltd.	1752	Taiwan	$103.55M	1,735
Hana Pharm. Co., Ltd.	293480	South Korea	$108.98M	327
VENTURE LIFE GROUP PLC	VLG	United Kingdom	$107.94M	514
DONGWHA PHARM.CO.,LTD	000020	South Korea	$105.83M	1,106
WHANIN PHARM CO.,LTD	016580	South Korea	$122.96M	789
ILSUNG IS CO., LTD.	003120	South Korea	$95.52M	1,113
Vistin Pharma	VISTN	Norway	$94.57M	578
BIOHARVEST SCIENCES INC.	BHST	Canada	$72.31M	179
Bioton S.A.	BIO	Poland	$96.53M	728
FITLIFE BRANDS, INC.	FTLF	United States of America	$92.69M	549
JEIL PHARMA HOLDINGS INC.	002620	South Korea	$80.47M	668
Vetnostrum Animal Health Co., Ltd.	6936	Taiwan	$78.51M	377
ILDONG HOLDINGS CO.,LTD	000230	South Korea	$49.05M	1,342
CKD Bio Corp.	063160	South Korea	$45.36M	611
Kukje Pharma Co., Ltd.	002720	South Korea	$48.42M	1,269
TSH Biopharm Corporation Limited	8432	Taiwan	$60.77M	1,510
Aprogen, Inc	007460	South Korea	$32.19M	2,022
TURK İLAÇ VE SERUM SANAYİ A.Ş.	TRILC	Türkiye	$28.33M	744
PharmGen Science, Inc.	004720	South Korea	$58.45M	1,324
Navamedic	NAVA	Norway	$54.65M	1,072
Lifevantage Corp	LFVN	United States of America	$78.72M	1,250
Stablecoin Development Corp	SDEV	United States of America	$51.92M	1,320
GenMont Biotech Inc.	3164	Taiwan	$43.90M	2,007
Sfd Spolka Akcyjna	SFD	Poland	$47.49M	790

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

genericsOTCAPI manufacturerbiosimilars

Not here

makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Sent here from

Other classes in Pharmaceuticals

Branded Prescription Drugs RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Also big pharma, innovative pharmaceuticals, animal health

Not here no approved product → CLB Clinical-Stage Biotech
Not here approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
Not here mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Permanent link

https://financialfilings.com/oics/GNX/

This page is keyed by the class ID GNX. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard